The data discovery software provider, which is set to be acquired by Eldridge Industries, will receive funding from Snowflake’s strategic investment arm.
Author: Jordan Williams
Cycle Capital revolves to $145m fund close
Rio Tinto, Suez, La Capitale, Hydro-Québec and Innergex helped venture capital firm Cycle Capital reach the final close of its latest cleantech-focused fund.
Quicktron stores $100m in series C-plus round
Kion Group and Prosperity7 Ventures co-led a round for the warehouse robot developer, which plans to expand to more than 100 countries in the next five years.
Neuron23 comes out of stealth with $114m
Biopharmaceutical company Origenis helped form the neurological and immunological disease drug developer, which has revealed series A and B funding.
Cazoo agrees Drover purchase
The flexible car rental service has agreed to be acquired, having raised nearly $40m from investors including BP, Shell and Channel 4.
Corporates drive dMed’s $100m series C
Kaiser Foundation Hospitals and Lilly Asia Ventures backed a round for the pharmaceutical research services provider that was led by Fidelity.
MinervaX rakes in series B funding
Novo’s Repair Impact Fund and Sanofi Ventures were among the investors in a $57.6m round that will fund work on MinervaX’s group B Streptococcus vaccine.
BigID becomes unicorn through $70m series D
Salesforce Ventures co-led a round that pushed the data protection software developer’s valuation past the $1bn mark.
Sensata supports Uhnder’s $45m series C
Sensata Technologies led the latest round for the radar chipmaker, which also counts Edom, TDK, Lockheed Martin, SAIC Motors, Fosun and Qualcomm as backers.
StockX stacks up $275m series E
The GV-backed consumer goods marketplace hit a $2.8bn valuation in a Tiger Global-led series E round, which brings its total funding to $490m.
Lydia lifts series B round to $131m
The Tencent and CNP Assurances-backed round has been boosted by $86m and the banking app developer has now pulled in over $160m in total.
Nference nails $60m series C
Mayo Clinic had invested in and partnered the medical data software provider before joining a series C round also featuring NTTVC.
Bioeconomy fund bags $213m second close
The European Commission-backed venture fund has secured commitments from Nestlé, Volkswohl Bund Versicherungen and Neste for its second close.
Locanabio lands $100m in series B
UCB Ventures and GV returned for the neurodegenerative, neuromuscular and retinal disease drug developer’s series B round.